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To the Editor 
Despite recurrent hospitalizations for heart failure exacerbations the underlying 
etiology can be missed. Senile amyloidosis is a disease prevalent in the elderly African 
American population. Senile amyloidosis is underdiagnosed as a cause of heart failure 
due to its occurrence with more common comorbidities such as long standing systemic 
hypertension.  It is important to maintain a high index of suspicion for senile amyloidosis 
in patients such as this case, who presented with multiple exacerbations of heart failure 
combined with characteristic electrocardiographic and echocardiographic findings. 
 
Clinical Presentation 
This is the case of a 71-year-old African American male with non-ischemic 
cardiomyopathy presumed secondary to hypertensive heart disease that presented with 
heart failure symptoms. He had previous hospitalizations for heart failure exacerbations 
in the past 2 years.  
The patient’s medical regimen included an angiotensin converting enzyme 
inhibitor (ACE-I), beta-blocker and a thiazide diuretic. EKG showed low voltage QRS 
complexes in all leads. The brain natriuretic peptide (BNP) was elevated. Chest x-ray 
revealed bilateral pleural effusions with an enlarged heart. Transthoracic 
echocardiography revealed marked biventricular hypertrophy, global hypokinesis,  
severe diastolic dysfunction and dilated atria; suggestive of infiltrative cardiomyopathy 
(Figure 1).  Echocardiogram from 6 months earlier revealed the same findings. Serum 
and urine protein electrophoresis, serum free light chains and immunoglobulins, and a 
fat pad biopsy were unremarkable. Bone marrow biopsy demonstrated hypercellular 
marrow and polyclonal plasmacytosis which ruled out plasma cell dyscrasias. 
 
Discussion 
There are significant findings in this case that leads to the correct but previously missed 
diagnosis. The ECG showed low voltage limb leads. The echocardiogram revealed 
biventricular hypertrophy, global hypokinesis, dilated atria, and a restrictive pattern 
suggestive of infiltrative cardiomyopathy. This combination of EKG and 
echocardiographic findings should raise clinical suspicion for amyloidosis, which is the 
most common prototype of infiltrative heart disease with increased wall thickness.[1] 
The endomyocardial biopsy showed amyloid deposition, specifically wild type 
transthyretrein protein deposition. 
 
Amyloidosis is an infiltrative multisystem disease with the severity of specific organ 
involvement (including the heart) dependent on the precursor protein.[2] There are 
different types, but the case presented is that of the senile cardiac amyloidosis. Senile 
cardiac amyloidosis almost always affects men in their seventies as a slow progressive 
disease with only cardiac involvement.[3] The first signs of senile cardiac amyloidosis 
are usually leg swelling or shortness of breath, both due to congestive heart failure.[4] 
 
Therapy for senile cardiac amyloidosis is, at present, purely symptomatic relief. 
Medications for heart failure, such as ACE-I, beta-blocker and diuretics are still the 
mainstay for treatment. Patients with senile cardiac amyloidosis however, not 
uncommonly progress to complete heart block, and permanent pacing becomes 
necessary.[5] Prompt referral to advanced heart failure physicians may improve quality 
of life and reduce readmissions due to heart failure exacerbations in such patients. 
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Figure Legend 
Figure 1. Parasternal long axis view on transthoracic echocardiogram demonstrating 
biventricular hypertrophy and left atrial enlargement 
 
 
 
 
